Oxford, United Kingdom

Richard Edward Moxon

USPTO Granted Patents = 6 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Richard Edward Moxon: Innovator in Vaccine Development

Introduction

Richard Edward Moxon is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of vaccine development, holding a total of 6 patents. His work focuses on innovative solutions for treating diseases through immunogenic components.

Latest Patents

Moxon's latest patents include a groundbreaking vaccine designed for the treatment of diseases caused by specific serogroups. This vaccine incorporates one or more immunogenic components, along with antibodies to these components. The methods outlined in his patents aim to prevent and treat infections effectively. Notably, the immunogens are based on elements of the inner core lipopolysaccharide, showcasing Moxon's commitment to advancing medical science.

Career Highlights

Throughout his career, Richard Edward Moxon has worked with notable organizations, including Isis Innovation Limited and the National Research Council of Canada. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to vaccine research.

Collaborations

Moxon has collaborated with esteemed colleagues such as James C Richards and Andrew Cox. These partnerships have played a crucial role in the development of his innovative vaccine technologies.

Conclusion

Richard Edward Moxon stands out as a key figure in the realm of vaccine innovation. His dedication to improving public health through scientific advancements is evident in his numerous patents and collaborations. His work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…